News from Datamonitor

August 13, 2007
Research and Development, Sales and Marketing

Alnylam lands $38.6 million federal government contractAlnylam Pharmaceuticals has been awarded a $38.6 million contract over 33 months from the …

The NHS and pharma: Let’s work together

August 13, 2007
Research and Development, Sales and Marketing NHS, healthcare, industry relations, joint working, pharma

In the last 10 years, pharma’s relationship with the NHS has undergone a transformation. For one thing, it’s difficult now …

NICE claims victory in Alzheimer’s court case

August 10, 2007
Sales and Marketing Alzheimer's

NICE will have to issue new guidance on Alzheimer's drugs, but claims the ruling in the judicial review vindicates its …

NICE to re-think blindness drugs decision

August 9, 2007
Sales and Marketing AMD, Lucentis, Macugen, NICE

NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …

FDA approves Pfizer’s first-in-class HIV drug

August 8, 2007
Sales and Marketing HIV

Pfizer has won US approval for Selzentry, making it the first new class of oral HIV medicines to reach the …

Indian court dismisses Novartis patent claim

August 8, 2007
Sales and Marketing India, Novartis

Novartis has failed in its challenge to India's intellectual property laws as part of its attempt to secure a patent …

Bayer buoyed by Schering integration

August 8, 2007
Sales and Marketing

Bayer more than doubled its second quarter pharma sales, which rose to €2.6 billion on the back of the group's …

First national dementia strategy planned

August 7, 2007

Plans have been unveiled for the first-ever national dementia strategy as the scale of the problem becomes clear.The number of …

Close encounters with the NHS

August 6, 2007
Research and Development, Sales and Marketing NHS, healthcare, industry relations, pharma

Most marketers in the pharma industry understand the need to get alongside and talk to key people in the NHS …

News roundup from Datamonitor

August 3, 2007
Sales and Marketing

Astion's lupus drug to receive orphan statusEuropean health authorities have recommended that Copenhagen-based Astion Pharma's cutaneous lupus erythematosus candidate be …

FDA allows Avandia to stay but damage already done

August 3, 2007
Sales and Marketing diabetes

An FDA advisory committee has recommended that GlaxoSmithKline's diabetes treatment Avandia should remain available on the US market, albeit with …

Germany loses out in Astellas restructuring

August 2, 2007
Sales and Marketing Astellas, Germany

Astellas has announced streamlining and cutbacks to its operations across Europe, with operations in Germany losing staff in its saleforce …

Tough talking ahead as government signals end to UK medicines pricing deal

August 2, 2007
ABPI, par

The government has told the UK pharmaceutical industry it wants to talk about the future of medicines pricing in the …

ReNeuron acquires Californian base and new diabetes technology

August 2, 2007
Research and Development

Pioneering British stem cell research company ReNeuron has bought the Californian company, AmCyte – a move it hopes will make …

Prevenar success boosts UK manufacturing

July 30, 2007
Manufacturing and Production

Wyeth has increased the capacity at its manufacturing site in Havant, Hampshire in response to growing demand for its vaccine …

Continuous dose contraceptive launched in US

July 30, 2007
Sales and Marketing contraception

Wyeth's Lybrel, the first ever contraceptive pill designed to be taken by women 365 days a year, has been launched …

Are you connecting with your customers?

July 30, 2007
Sales and Marketing customers, marketing

Insights (or customer insights) seems to be the current buzzword in the pharmaceutical industry. But is it something we should …

Latest news from Datamonitor

July 27, 2007
Research and Development, Sales and Marketing

BioMS's multiple sclerosis trial gets positive reviewBioMS Medical's relapsing-remitting multiple sclerosis trial has received a positive review from the data …

AstraZeneca to make further job cuts

July 26, 2007
Sales and Marketing

Thousands of employees in sales, marketing, R&D and back office staff will lose their jobs at AstraZeneca as the pharma …

Animal rights attacks fall to new low

July 26, 2007
Sales and Marketing

Attacks by animal rights extremists in the UK have dropped to a new low – but the pharmaceutical industry says …

The Gateway to Local Adoption Series

Latest content